Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release

American Journal of Hypertension

Volumn 10, Issue 6, 1997, Pages 662-670

  Li, Ping ^a   Ferrario, Carlos M ^a   Ganten, Detlev ^a   Brosnihan, K Bridget ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; Estrogen; Hormone replacement; Nitric oxide; Post menopausal; Renin gene; Transgenic rats; Vascular reactivity

Indexed keywords

ESTROGEN; NITRIC OXIDE; RENIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; ESTROGEN THERAPY; FEMALE; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC ANIMAL; VASCULAR ENDOTHELIUM;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HYPERTENSION; NITRIC OXIDE; RATS; RENIN;

EID: 0030738568     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00039-3     Document Type: Article

References (49)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 265:1991;1861-1867.
2. London GM, Guerin AP, Pannier B, et al. Influence of sex on arterial hemodynamics and blood pressure: role of body weight. Hypertension. 26:1995;514-519.
3. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prevent Med. 20:1991;47-63.
4. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N Engl J Med. 325:1991;756-762.
5. Nabulsi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 328:1993;1069-1075.
6. Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 325:1991;1196-1204.
7. Clarkson TB, Anthony MS, Klein KP. Effects of estrogen treatment on arterial wall structure and function. Drugs. 47:1994;42-51.
8. Gilabert J, Estelles A, Cano A, et al. The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in post menopausal status. Am J Obstet Gynecol. 173:1995;1849-1854.
9. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA. 89:1992;11259-11263.
10. Weiner CP, Lizasoain I, Baylis SA, et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
11. Goetz RM, Morano I, Calovini T, et al. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun. 205:1994;905-910.
12. Veille JC, Li P, Eisenach JC, et al. Release, biosynthesis and vasorelaxant activity of nitric oxide in sheep uterine and renal arteries in vitro: influence of estrogen. Am J Obstet Gynecol. 174:((3)):1996;1043-1049.
13. Hisikawa K, Nakaki T, Marumo T, et al. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:1995;290-293.
14. Collins P, Rosano GMC, Sarrel PM, et al. 17β -Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
15. Gilligan DM, Badar DM, Panza JA, et al. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol. 75:1995;264-268.
16. Rosselli M, Imthurn B, Keller PJ, et al. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β -estradiol and norethisterone acetate. Hypertension. 25:1995;848-853.
17. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 20:1992;452-457.
18. Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension. 157:1987;163.
19. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension. 8:((suppl II)):1986;II-61-II-66.
20. Williams SP, Shackelford DP, Iams SG, Mustafa SJ. Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur J Pharmacol. 145:1988;205-207.
21. Eiff AW, Lutz HM, Gries J, Kretzschmar R. The protective mechanism of estrogen on high blood pressure. Basic Res Cardiol. 80:1985;191-201.
22. Brosnihan KB, Moriguchi A, Nakamoto H, et al. Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am J Hypertens. 7:1994;576-582.
23. Bachmann J, Ganten U, Stock G, Ganten D. Sexueller dimorphismus des blutdrucks bei TGR(mREN2)27: einflu & szlig; von Androgenen. Nieren-und Hochdruckkrankheiten. 21:1992;599-601.
24. Moriguchi A, Brosnihan KB, Kumagai H, et al. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 266:1994;R1273-8.
25. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(I-7) in spontaneously hypertensive rats. Am J Physiol: Heart Circ Physiol. 269:1995;H313-H319.
26. G-monomethyl-L-arginine. Br J Pharmacol. 110:1993;1003-1008.
27. Hoeg JM, Willis LR, Weinberger MH. Estrogen attenuation of the development of hypertension in spontaneously hypertensive rats. Am J Physiol. 233:1977;369-373.
28. Magness RR, Parker CR Jr., Rosenfeld CR. Systemic and uterine responses to chronic infusion of estradiol- 17β Am J Physiol (Endocrinol Metab). 265:1993;E690-E698.
29. Pfeffer RI, Kurosaki TT, Charlton SK. Estrogen use and blood pressure in later life. Am J Epidemiol. 110:1979;469-478.
30. Sturtevant FM. Hypotensive activity of natural and synthetic estrogens in metacorticoid hypertensive rats. Proc Soc Exp Biol Med. 93:1956;550-551.
31. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 92:1995;3431-3435.
32. Butcher RL, Collins WE, Fugo NW. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol- 17β throughout the 4-day estrous cycle of the rat. Endocrinology. 94:1974;1704-1708.
33. Williams JK, Anthony MS, Honore EK, et al. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 15:1995;827-836.
34. Bachmann J, Feldmer M, Ganten U, et al. Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem. 40:1991;511-515.
35. Luotola H. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution. Ann Clin Res. 15:1983;S1-S121.
36. Sitruk-Ware R, Ibarra de Palacios P. Oestrogen replacement therapy and cardiovascular disease in post-menopausal women. Maturitas. 11:1989;259-274.
37. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 344:1990;541-544.
38. Moriguchi A, Tallant EA, Matsumura K, et al. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 25:1995;1260-1265.
39. Wagner J, Thiele F, Ganten D. Transgenic animals as models for human disease. Clin Exp Hypertens. 17:1995;593-605.
40. Zhao Y, Bader M, Kruetz R, et al. Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats, TGR (mRen2) 27. Am J Physiol. 265:1993;E699-E707.
41. Bachmann S, Peters J, Engler E, et al. Transgenic rats carrying the mouse renin gene - morphological characterization of a low-renin hypertension model. Kidney Int. 41:1992;24-36.
42. Tschudi MR, Noll G, Arnet U, et al. Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. Circulation. 89:1994;2780-2786.
43. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
44. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:1991;109-141.
45. Luscher TF. Imbalance of endothelium-derived relaxing and contracting factors: a new concept in hypertension? Am J Hypertens. 3:1990;317-330.
46. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:1996;239-242.
47. Hecker M, Bara AT, Bauerachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol. 481:1994;407-414.
48. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17-β estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 244:1988;19-22.
49. Christie MI, Griffith TM, Lewis MJ. A comparison of basal and agonist-stimulated release of endothelium-derived relaxing factor from different arteries. Br J Pharmacol. 98:1989;397-406.